Testing effectiveness (Phase 2)WithdrawnNCT04776876
What this trial is testing
Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome
Who this might be right for
Advanced Neuroendocrine NeoplasmCarcinoid Syndrome
M.D. Anderson Cancer Center